WOCKHARDT
Quarterly Results Analysis [Mar2025]
WOCKHARDT Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 Audited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹743 Cr | ₹721 Cr | ₹809 Cr | ₹739 Cr | ₹700 Cr | ₹701 Cr | ₹753 Cr | ₹644 Cr |
Expenses | ₹679 Cr | ₹593 Cr | ₹699 Cr | ₹648 Cr | ₹803 Cr | ₹664 Cr | ₹681 Cr | ₹628 Cr |
Operating Income | ₹64 Cr | ₹128 Cr | ₹110 Cr | ₹91 Cr | ₹-103 Cr | ₹37 Cr | ₹72 Cr | ₹16 Cr |
Other Income | ₹15 Cr | ₹8 Cr | ₹9 Cr | ₹30 Cr | ₹54 Cr | ₹8 Cr | ₹24 Cr | ₹14 Cr |
Interest | ₹48 Cr | ₹60 Cr | ₹73 Cr | ₹73 Cr | ₹73 Cr | ₹77 Cr | ₹76 Cr | ₹79 Cr |
Depreciation | ₹53 Cr | ₹55 Cr | ₹55 Cr | ₹54 Cr | ₹58 Cr | ₹55 Cr | ₹55 Cr | ₹55 Cr |
Profit Before Tax | ₹-22 Cr | ₹21 Cr | ₹-9 Cr | ₹-6 Cr | ₹-180 Cr | ₹-87 Cr | ₹-35 Cr | ₹-118 Cr |
Profit After Tax | ₹-45 Cr | ₹20 Cr | ₹-16 Cr | ₹-16 Cr | ₹-177 Cr | ₹-86 Cr | ₹-73 Cr | ₹-136 Cr |
EPS | ₹-1.54 | ₹0.86 | ₹-1.43 | ₹-0.91 | ₹-10.97 | ₹-5.76 | ₹-5.35 | ₹-9.31 |
Industry Peers & Returns | 1W | 1M | 1Y |
WOCKHARDT | 3.2% | -1.5% | 99.4% |
SUN PHARMACEUTICAL INDUSTRIES | -0.4% | -0.9% | 4.8% |
DIVIS LABORATORIES | -0.7% | 1.6% | 50.2% |
CIPLA | -1.7% | -1.1% | -2.3% |
TORRENT PHARMACEUTICALS | -1.1% | 1.6% | 13.7% |
DR REDDYS LABORATORIES | -4.3% | -8% | -4.4% |
MANKIND PHARMA | 6.8% | 8% | 20.9% |
ZYDUS LIFESCIENCES | -1.9% | 0.1% | -16.5% |
LUPIN | -4.3% | -6.4% | 4.6% |
WOCKHARDT Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 3.05 % |
Y-o-Y | 6.14 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹743 Cr | 3.05 | |
Dec2024 | ₹721 Cr | -10.88 | |
Sep2024 | ₹809 Cr | 9.47 | |
Jun2024 | ₹739 Cr | 5.57 | |
Mar2024 | ₹700 Cr | -0.14 | |
Dec2023 | ₹701 Cr | -6.91 | |
Sep2023 | ₹753 Cr | 16.93 | |
Jun2023 | ₹644 Cr | - |
WOCKHARDT Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -50.00 % |
Y-o-Y | Positive |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹64 Cr | -50.00 | |
Dec2024 | ₹128 Cr | 16.36 | |
Sep2024 | ₹110 Cr | 20.88 | |
Jun2024 | ₹91 Cr | Positive | |
Mar2024 | ₹-103 Cr | Negative | |
Dec2023 | ₹37 Cr | -48.61 | |
Sep2023 | ₹72 Cr | 350.00 | |
Jun2023 | ₹16 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -51.49 % |
Y-o-Y | Positive |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 8.61% | -51.49 | |
Dec2024 | 17.75% | 30.51 | |
Sep2024 | 13.6% | 10.48 | |
Jun2024 | 12.31% | Positive | |
Mar2024 | -14.71% | Negative | |
Dec2023 | 5.28% | -44.77 | |
Sep2023 | 9.56% | 285.48 | |
Jun2023 | 2.48% | - |
WOCKHARDT Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹-45 Cr | Negative | |
Dec2024 | ₹20 Cr | Positive | |
Sep2024 | ₹-16 Cr | Negative | |
Jun2024 | ₹-16 Cr | Negative | |
Mar2024 | ₹-177 Cr | Negative | |
Dec2023 | ₹-86 Cr | Negative | |
Sep2023 | ₹-73 Cr | Negative | |
Jun2023 | ₹-136 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | -6.06 % | Negative | |
Dec2024 | 2.77 % | Positive | |
Sep2024 | -1.98 % | Negative | |
Jun2024 | -2.17 % | Negative | |
Mar2024 | -25.29 % | Negative | |
Dec2023 | -12.27 % | Negative | |
Sep2023 | -9.69 % | Negative | |
Jun2023 | -21.12 % | - |
WOCKHARDT Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹-1.54 | Negative | |
Dec2024 | ₹0.86 | Positive | |
Sep2024 | ₹-1.43 | Negative | |
Jun2024 | ₹-0.91 | Negative | |
Mar2024 | ₹-10.97 | Negative | |
Dec2023 | ₹-5.76 | Negative | |
Sep2023 | ₹-5.35 | Negative | |
Jun2023 | ₹-9.31 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD